Humana Inc. (HUM) — Analysis Summary
Humana Inc. (HUM) has a market cap of $48.74B with year-over-year revenue growth of +10.1%. Net margin stands at 0.9%. The stock trades at a P/E ratio of 43.1.
Key Takeaways
- Revenue changed +10.1% year-over-year
- Net margin of 0.9%
- P/E ratio of 43.1
Compared to other companies in the HOSPITAL & MEDICAL SERVICE PLANS sector, HUM posted revenue growth of +10.1% and trades at a P/E of 43.1.
Humana Inc. (HUM)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsWatch List
Some caution signals are active and should be weighed alongside the valuation work.
Debt/EBITDA at 4.5x — elevated leverage
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Sector
HOSPITAL & MEDICAL SERVICE PLANS
Employees
67,060
Headquarters
LOUISVILLE, KY
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$3.54
Dividend Yield
0.87%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.